Apremilast EP Impurity E
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

2487573-03-3Apremilast EP Impurity E

● In Stock

Catalogue No.:VL6770005
CAS No.:2487573-03-3
Mol. Formula:C22H24N2O7S
Mol. Weight:460.5 g/mol

Additional information on CAS 2487573-03-3

Parent drug

Apremilast

IUPAC Name

N-(2-(1-(4-ethoxy-3-methoxyphenyl)-2-(methylsulfonyl)ethyl)-1, 3-dioxoisoindolin-4-yl)acetamide

Synonyms

rac-4’-O-Ethyl-3’-O-methyl Apremilast

Description

Apremilast EP Impurity E (CAS NO.-2487573-03-3) is an oral phosphodiesterase 4 inhibitor that has an impact on a wide range of inflammatory mediators involved in psoriasis and psoriatic arthritis, this is a novel treatment that focuses on maintaining a balance between pro-inflammatory and anti-inflammatory signals.

References

Schafer, Peter. “Apremilast Mechanism of Action and Application to Psoriasis and Psoriatic Arthritis.” Biochemical Pharmacology, vol. 83, no. 12, June 2012, pp. 1583–90, https://doi.org/10.1016/j.bcp.2012.01.001.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url